Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bussel

Showing results (401-410 of 487) with videos related to

Pageof 49
Sort By:
Pediatric Blood & Cancer|October 28, 2014
Long-term use of the thrombopoietin-mimetic romiplostim in children with severe chronic immune thrombocytopenia (ITP)James B Bussel, Loan Hsieh, George R Buchanan, et al.
British Journal of Haematology|February 27, 2004
Intravenous (IV) anti-D and IV immunoglobulin achieve acute platelet increases by different mechanisms: modulation of cytokine and platelet responses to IV anti-D by FcgammaRIIa and FcgammaRIIIa polymorphismsNichola Cooper, Nancy M Heddle, Masja Haas, et al.
Annals of the New York Academy of Sciences|October 29, 1993
Human immune development: implications for congenital HIV infectionS Cunningham-Rundles, C Chen, J B Bussel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1988
T cell antigen receptors in autoimmunityD N Posnett, A Gottlieb, J B Bussel, et al.
Haematologica|March 9, 2019
Long-term treatment with romiplostim and treatment-free platelet responses in children with chronic immune thrombocytopeniaMichael D Tarantino, James B Bussel, Victor S Blanchette, et al.
Blood|October 24, 2008
Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic reviewRoberto Stasi, Ameet Sarpatwari, Jodi B Segal, et al.
American Journal of Preventive Medicine|January 17, 2009
History of the Robert Wood Johnson Foundation's Active Living Research Program: origins and strategyC Tracy Orleans, Laura C Leviton, Kathryn A Thomas, et al.
American Journal of Obstetrics and Gynecology|June 29, 2025
Increased frequency of autism by previous diagnosis and screening in children with fetal-neonatal alloimmune thrombocytopenia with and without an intracranial hemorrhageEleanore A McFarland, Katherine A Knightly, Emilie Vander Haar, et al.
Thrombosis and Haemostasis|March 27, 2004
IGIV-C, a novel intravenous immunoglobulin: evaluation of safety, efficacy, mechanisms of action, and impact on quality of lifeJames B Bussel, Amiram Eldor, John G Kelton, et al.
American Journal of Hematology|May 7, 2019
Maternal sensitization occurs before delivery in severe cases of fetal alloimmune thrombocytopeniaJenny C Jin, Madhavi M Lakkaraja, Polina Ferd, et al.
Pageof 49

Showing results (401-410 of 487) with videos related to

Sort By:
Pageof 49
Pediatric Blood & Cancer|October 28, 2014
Long-term use of the thrombopoietin-mimetic romiplostim in children with severe chronic immune thrombocytopenia (ITP)James B Bussel, Loan Hsieh, George R Buchanan, et al.
British Journal of Haematology|February 27, 2004
Intravenous (IV) anti-D and IV immunoglobulin achieve acute platelet increases by different mechanisms: modulation of cytokine and platelet responses to IV anti-D by FcgammaRIIa and FcgammaRIIIa polymorphismsNichola Cooper, Nancy M Heddle, Masja Haas, et al.
Annals of the New York Academy of Sciences|October 29, 1993
Human immune development: implications for congenital HIV infectionS Cunningham-Rundles, C Chen, J B Bussel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1988
T cell antigen receptors in autoimmunityD N Posnett, A Gottlieb, J B Bussel, et al.
Haematologica|March 9, 2019
Long-term treatment with romiplostim and treatment-free platelet responses in children with chronic immune thrombocytopeniaMichael D Tarantino, James B Bussel, Victor S Blanchette, et al.
Blood|October 24, 2008
Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic reviewRoberto Stasi, Ameet Sarpatwari, Jodi B Segal, et al.
American Journal of Preventive Medicine|January 17, 2009
History of the Robert Wood Johnson Foundation's Active Living Research Program: origins and strategyC Tracy Orleans, Laura C Leviton, Kathryn A Thomas, et al.
American Journal of Obstetrics and Gynecology|June 29, 2025
Increased frequency of autism by previous diagnosis and screening in children with fetal-neonatal alloimmune thrombocytopenia with and without an intracranial hemorrhageEleanore A McFarland, Katherine A Knightly, Emilie Vander Haar, et al.
Thrombosis and Haemostasis|March 27, 2004
IGIV-C, a novel intravenous immunoglobulin: evaluation of safety, efficacy, mechanisms of action, and impact on quality of lifeJames B Bussel, Amiram Eldor, John G Kelton, et al.
American Journal of Hematology|May 7, 2019
Maternal sensitization occurs before delivery in severe cases of fetal alloimmune thrombocytopeniaJenny C Jin, Madhavi M Lakkaraja, Polina Ferd, et al.
Pageof 49